Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.59 - $2.44 $1,316 - $2,020
-828 Reduced 31.01%
1,842 $4,000
Q4 2023

Feb 13, 2024

SELL
$1.97 - $5.41 $1,790 - $4,917
-909 Reduced 25.4%
2,670 $5,000
Q3 2023

Nov 14, 2023

SELL
$4.84 - $7.13 $8,789 - $12,948
-1,816 Reduced 33.66%
3,579 $17,000
Q2 2023

Aug 21, 2023

BUY
$6.84 - $8.56 $75 - $94
11 Added 0.2%
5,395 $36,000
Q1 2023

May 09, 2023

SELL
$6.85 - $13.0 $2,719 - $5,161
-397 Reduced 6.87%
5,384 $38,000
Q4 2022

Feb 14, 2023

BUY
$11.99 - $14.5 $779 - $942
65 Added 1.14%
5,781 $74,000
Q3 2022

Nov 18, 2022

SELL
$12.03 - $14.22 $5,726 - $6,768
-476 Reduced 7.69%
5,716 $81,000
Q2 2022

Aug 15, 2022

BUY
$11.57 - $17.92 $71,641 - $110,960
6,192 New
6,192 $76,000

Others Institutions Holding AADI

About Aadi Bioscience, Inc.


  • Ticker AADI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,016,800
  • Market Cap $48.3M
  • Description
  • Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...
More about AADI
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.